Smoking Clinical Trial
Official title:
Evaluation of Tobacco Heating System (THS) Compared to Conventional Cigarette Smoking During the Closed Tibia Fracture Healing in Orthopedic Smokers' Patients
The goal of this clinical trial is to investigate the role of switching from cigarette smoking (CS) to tobacco heat system (THS) on the clinical outcome of closed tibia fractures from smokers' orthopedic patients. Validated and standardized assays, medical state and self-reported outcomes will be evaluated in orthopedic patients' smokers or switch from CS to using THS throughout six months compare to ex-smokers (control).
Status | Recruiting |
Enrollment | 150 |
Est. completion date | April 17, 2026 |
Est. primary completion date | October 15, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years and older |
Eligibility | Inclusion Criteria: - Closed tibial fracture (according to AO/OTA classification: 41A2-41C3, 42A-C, 43A-C) which is surgically treated within 14 days after the trauma at the BG trauma clinic Tübingen. Additional inclusion criteria for the smoking and THS groups: - Smokers with 10-20 packyears smoking history. - Smoking history >10 years. - Decision not to participate in the free smoking cessation seminars. Exclusion Criteria: - Legal guardian or loss of capacity to consent. - Refusal to participate in the study. - Open tibial fractures or concomitant injuries or complications requiring surgery existing at the time of surgical indication. - Initial surgical treatment of the tibial fracture has occurred ex domo. - No initial surgical treatment within 14 days of sustained trauma. - Using nicotine delivery electronic devices. - Pre-existing autoimmune, immunological, bone or malignant diseases. - Pregnant, breastfeeding and women of childbearing age with existing desire to have children. - History of alcohol abuse or drug abuse. - Taking antioxidants approval by the German Federal Institute for Drugs and Medical Devices (BfArM). - Taking drugs with known effect on bone metabolism (according to Institute for medical and pharmaceutical examination issues (IMPP): allosteric CaSR modulators, bisphosphonates, calcium release inhibitors, alkaline earth ions, RANKL inhibitors, calcitriol, colecalciferol). |
Country | Name | City | State |
---|---|---|---|
Germany | Siegfried Weller Institutes, BG-Trauma Clinic, Department of Traumatology, Eberhard Karls University Tübingen | Tübingen | Baden-Württemberg |
Lead Sponsor | Collaborator |
---|---|
University Hospital Tuebingen | Philip Morris Products S.A. |
Germany,
Aspera-Werz RH, Ehnert S, Muller M, Zhu S, Chen T, Weng W, Jacoby J, Nussler AK. Assessment of tobacco heating system 2.4 on osteogenic differentiation of mesenchymal stem cells and primary human osteoblasts compared to conventional cigarettes. World J Stem Cells. 2020 Aug 26;12(8):841-856. doi: 10.4252/wjsc.v12.i8.841. — View Citation
Weng W, Bovard D, Zanetti F, Ehnert S, Braun B, Uynuk-Ool T, Histing T, Hoeng J, Nussler AK, Aspera-Werz RH. Tobacco heating system has less impact on bone metabolism than cigarette smoke. Food Chem Toxicol. 2023 Mar;173:113637. doi: 10.1016/j.fct.2023.113637. Epub 2023 Jan 25. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Concentration of Soluble intercellular adhesion molecule-1 (sICAM-1) | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Concentration of High densitiy lipoprotein cholesterol levels (HDL) | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Concentration of Leucocytes | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Concentration of Erythrocytes | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Concentration of Hemoglobin | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Concentration of Thrombocytes | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Mean corpuscular volume | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Hematocrit levels | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Mean corpuscular hemoglobin levels | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Corpuscular hemoglobin concentration | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Protein c reactive levels | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Other | Alcohol consume | Compensation cigarette abstinence with alcohol | 6 months after tibia surgery | |
Other | Questionnaire on Smoking Urges (QSU-G) - Score | 6 months after tibia surgery | ||
Other | Smoking behaviour | Number of cigarettes or THS heets consume | 6 months after tibia surgery | |
Other | Nicotine withdrawal syndrome assessment - Checklist | 6 months after tibia surgery | ||
Primary | Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP) | Marker collagen formation - bone formation | 6 months after tibia fracture surgery | |
Secondary | Concentration of Alkaline Phosphatase (BAP) | Marker osteoblast activity | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | |
Secondary | Concentration of Osteoprogesterin | Decoy receptor RANKL - inhibit osteoclast differentiation | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | |
Secondary | Concentration of Osteopontin | Extracellular structural protein and an organic component of bone - favors osteoclast adherence | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | |
Secondary | Concentration of N-terminal telopeptide (NTx) | Marker collagen degradation - bone resorption | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | |
Secondary | Concentration of Interleukin 1 beta (IL-1ß) | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Secondary | Concentration of Interleukin 6 (IL-6) | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Secondary | Concentration of Interferon gamma (IFN-?) | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Secondary | Concentration of Tumor Necrosis Factor Alpha (TNF-a) | 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery) | ||
Secondary | Number of bridged cortices in conventional X-ray | 6 months after tibia fracture surgery | ||
Secondary | Number of bridged cortices in computed tomography scan | 6 months after tibia fracture surgery | ||
Secondary | Bone Stiffness by a CT-based finite element method | Finite element method will be used to simulate the mechanical behavior (linear-elastic range) of the tibia and predict bending stiffness under a 3-point bending test | 6 months after tibia fracture surgery | |
Secondary | Functional index in trauma (FIX-IT) - Score | Assess weight-bearing and pain in patients with lower extremity fractures eight-bearing and pain in patients with lower extremity fractures. The score rank from 0 to 12 points in 2 domains: the ability to bear weight (maximum 6 points) and pain at the fracture site (maximum 6 points). The scores in both domains, which are weighted equally, are summed to obtain the final total score; (maximum 12 points indicates the highest level of function). | 6 months after tibia fracture surgery | |
Secondary | Loading of the injured extremity | The time period with no, sole contact, partial or full load on the injured extremity. | 6 months after tibia fracture surgery | |
Secondary | Lower Extremity Functional Scale (LEFS) - Score | The Lower Extremity Functional Scale (LEFS) is a questionnaire (20 questions) about a person's ability to perform everyday tasks. The LEFS will be used to evaluate the functional impairment of a patient with a disorder of lower extremity. The score rank from 0 to 80 points. The maximum score (80 point) indicates no functional limitations. | 6 months after tibia fracture surgery | |
Secondary | Number of complications associated with the healing process | 6 months after tibia fracture surgery | ||
Secondary | Number of hospital stay and incapacity to work [days] | 6 months after tibia fracture surgery | ||
Secondary | Physicians Global Assessment to measure quality of life (PROMIS GH10 v 1.2) - Score | The Global Health Patient-Reported Outcomes Measurement Information System (PROMIS- 10) scale is a ten-item patient reported measure of physical, mental and social health. Two summary scores are calculated from the results of the questions: a global physical health score and a global mental health score. These scores are then normalized to the general population using the "T-score." The score ranges from 0 to 20 points. 0 points represent the most severe physical and/or mental impairment of the patient, while 20 points represent the best possible health status. | 6 months after tibia fracture surgery | |
Secondary | Visual Analog Score for pain (VAS) - Score | Visual Analog Scale for Pain (VAS) provide an estimate of patients' pain intensity. Scale from cero (no pain) to 10 (extreme pain). | 6 months after tibia fracture surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02649556 -
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Completed |
NCT03305978 -
Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.
|
N/A | |
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Active, not recruiting |
NCT02752022 -
Monitoring the Transition From Smoking to E-cigarettes
|
||
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT02901171 -
The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02912000 -
TEACH: Technology Evaluation to Address Child Health
|
N/A | |
Completed |
NCT02949648 -
Electronic Cigarette Use and Quitting in Youth
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT02246114 -
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|
N/A | |
Completed |
NCT02008292 -
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
|
N/A | |
Completed |
NCT01898507 -
Nicotine Metabolism and Low Nicotine Cigarettes
|
N/A | |
Completed |
NCT01954407 -
Young Adults' Responses to Anti-smoking Messages
|
N/A |